AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA

被引:0
|
作者
Dogan N. [1 ]
Mijnheer B.J. [2 ]
Padgett K. [1 ]
Nalichowski A. [3 ]
Wu C. [4 ]
Nyflot M.J. [5 ]
Olch A.J. [6 ]
Papanikolaou N. [7 ]
Shi J. [8 ]
Holmes S.M. [9 ]
Moran J. [10 ]
Greer P.B. [11 ,12 ]
机构
[1] Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL
[2] Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam
[3] Department of Radiation Oncology, Karmanos Cancer Institute, Detroit, MI
[4] Department of Radiation Oncology, Sutter Medical Foundation, Roseville, CA
[5] Department of Radiation Oncology, University of Washington, Seattle, WA
[6] Department of Radiation Oncology, University of Southern California, and Children's Hospital Los Angeles, Los Angeles, CA
[7] Division of Medical Physics, UT Health-MD Anderson, San Antonio, TX
[8] Sun Nuclear Corporation – A Mirion Medical Company, Melbourne, FL
[9] Standard Imaging, Inc., Middleton, WI
[10] Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY
[11] Department of Radiation Oncology, Calvary Mater Newcastle Hospital, Newcastle, NSW
[12] School of Information and Physical Sciences, University of Newcastle, Newcastle, NSW
关键词
electronic portal imaging device; EPID; EPID QA; IMRT/VMAT QA; patient-specific EPID QA;
D O I
10.1002/mp.16536
中图分类号
学科分类号
摘要
Purpose: Electronic portal imaging devices (EPIDs) have been widely utilized for patient-specific quality assurance (PSQA) and their use for transit dosimetry applications is emerging. Yet there are no specific guidelines on the potential uses, limitations, and correct utilization of EPIDs for these purposes. The American Association of Physicists in Medicine (AAPM) Task Group 307 (TG-307) provides a comprehensive review of the physics, modeling, algorithms and clinical experience with EPID-based pre-treatment and transit dosimetry techniques. This review also includes the limitations and challenges in the clinical implementation of EPIDs, including recommendations for commissioning, calibration and validation, routine QA, tolerance levels for gamma analysis and risk-based analysis. Methods: Characteristics of the currently available EPID systems and EPID-based PSQA techniques are reviewed. The details of the physics, modeling, and algorithms for both pre-treatment and transit dosimetry methods are discussed, including clinical experience with different EPID dosimetry systems. Commissioning, calibration, and validation, tolerance levels and recommended tests, are reviewed, and analyzed. Risk-based analysis for EPID dosimetry is also addressed. Results: Clinical experience, commissioning methods and tolerances for EPID-based PSQA system are described for pre-treatment and transit dosimetry applications. The sensitivity, specificity, and clinical results for EPID dosimetry techniques are presented as well as examples of patient-related and machine-related error detection by these dosimetry solutions. Limitations and challenges in clinical implementation of EPIDs for dosimetric purposes are discussed and acceptance and rejection criteria are outlined. Potential causes of and evaluations of pre-treatment and transit dosimetry failures are discussed. Guidelines and recommendations developed in this report are based on the extensive published data on EPID QA along with the clinical experience of the TG-307 members. Conclusion: TG-307 focused on the commercially available EPID-based dosimetric tools and provides guidance for medical physicists in the clinical implementation of EPID-based patient-specific pre-treatment and transit dosimetry QA solutions including intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) treatments. © 2023 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.
引用
收藏
页码:e865 / e903
页数:38
相关论文
共 50 条
  • [21] Multi-task autoencoder based classification-regression model for patient-specific VMAT QA
    Wang, Le
    Li, Jiaqi
    Zhang, Shuming
    Zhang, Xile
    Zhang, Qilin
    Chan, Maria F.
    Yang, Ruijie
    Sui, Jing
    PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (23):
  • [22] Influence of dose specification on prostate VMAT patient-specific QA results
    Clemente Gutierrez, F.
    Perez Vara, C.
    Clavo Herranz, M.
    Lopez Carrizosa, C.
    Saez Garrido, J.
    Ibanez Villoslada, C.
    Couselo Paniagua, M.
    Zapatero Ortuno, J.
    Martin de Miguel, M.
    Dominguez Morcillo, M.
    Jerviz Guia, V.
    Calapaqui Teran, A.
    Guijarro Verdu, M.
    Navarro, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S726 - S726
  • [23] A single-optical kernel for a phosphor-screen-based geometric QA system (RavenQA™) as a tool for patient-specific IMRT/VMAT QA
    Lee, Minsik
    Ding, Kai
    Yi, ByongYong
    PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (20):
  • [24] Characterization of a New Commercially Available System for Patient Specific IMRT/VMAT QA
    Stathakis, S.
    Myers, P.
    Esquivel, C.
    Gutierrez, A.
    Mavroidis, P.
    Papanikolaou, N.
    MEDICAL PHYSICS, 2012, 39 (06) : 3782 - 3782
  • [25] Modulation Severity as a Predictor for Patient-Specific IMRT QA Delivery Failure
    Price, R.
    Veltchev, I.
    Ma, C.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [26] Intercomparison of Patient-Specific IMRT QA Devices for Small-Field, Stereotactic VMAT Treatments Using Gamma Index Analysis
    Alvarez, D.
    Wieczorek, D.
    Mishra, V.
    Gutierrez, A.
    MEDICAL PHYSICS, 2017, 44 (06) : 2957 - 2957
  • [27] Reduction of Systematic Dosimetric Uncertainties in VMAT Treatments Triggered by Patient-Specific QA
    Mijnheer, B.
    Janssen, T.
    van Mourik, A.
    Kaas, J.
    Damen, E.
    Mans, A.
    MEDICAL PHYSICS, 2019, 46 (06) : E245 - E245
  • [28] Clinical Implementation of Deep Learning-Based VMAT Patient-Specific QA
    Yang, X.
    Wang, L.
    Li, D.
    Guo, Y.
    Li, Y.
    Guan, Y.
    Wu, X.
    Xu, S.
    Zhang, S.
    Chan, M.
    Yang, R.
    Geng, L.
    Sui, J.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [29] On the Evaluation of Patient-Specific IMRT QA Using EPID, Dynalog Files, and Patient Anatomy
    Defoor, D.
    Mavroidis, P.
    Gutierrez, A.
    Papanikolaou, N.
    Stathakis, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S885 - S885
  • [30] Patient-Specific IMRT QA for Large Volume CyberKnife Plans Using MatriXX
    Veltchev, I.
    Lin, M.
    Price, R.
    Ma, C.
    MEDICAL PHYSICS, 2013, 40 (06)